Invention Symposium, San Mateo, CA at Biointerface Conference -
Gel-Del will be participating in the Invention Symposium at the
Biointerface Conference.   Full Story [PDF]

CosmetaLife™ starts trials-
The company began clinical trials of CosmetaLife™, a
gel-particle product for injection to correct wrinkles
at four of six planned U.S. sites this fall and expects
to conclude the trials in 2007. The company hopes to
introduce the product to the rapidly growing $1 billion
cosmetic augmentation market by the beginning of 2008.
Full Story [PDF]

Finance and Commerce - "Not Just a Player but a Leader" -
F&C's latest installment of its Focal Point series focuses
on health care and biomedical development. At the forefront of
the industry is Gel-Del Technologies and company president
David Masters.   Full Story [PDF]